Next-Generation Discovery Workflows Feb 3, 2022 Castle Biosciences Working With NCI on SEER Registry Study of DecisionDx-Melanoma Sep 9, 2021 Cedars-Sinai, Tempus Partner on Molecular Database Initiative Aug 5, 2021 NYU Langone Health, Philips Integrate Informatics for FDA-Cleared Cancer Sequencing Panel Premium Jul 2, 2021 Astronomy, Biology Come Together for Cancer Biomarker Discovery Premium Jun 4, 2021 Biodesix, Datavant Join in Lung Cancer Data Partnership May 12, 2021 Early-Stage Lung Cancer Development Traced in Single-Cell RNA Sequencing Study May 12, 2021 Heligenics, Jackson Lab Partner to Study Breast Cancer Gene Variants May 7, 2021 Indivumed, Oslo University Hospital Partner on AI-Driven Colorectal Cancer Research Apr 30, 2021 Transcriptomic Algorithm Shows Ability to Predict Progression-Free Survival in Cancer Patients Premium Apr 29, 2021 Geisinger Health System Wins $3.6M NIH Grant to Study Genetics of Cancer Risk Apr 27, 2021 BostonGene, Medical College of Wisconsin Partner on Pancreatic Cancer Biomarker Research Mar 26, 2021 Genome Sequencing Identifies Myeloma Precursor Disease With High Progression Risk Feb 9, 2021 Germline Genetic Variants May Influence Tumor Immune Microenvironment, Treatment Response Jan 27, 2021 Small Cell Lung Cancer Study Uncovers Disease-Associated Germline Mutations Jan 21, 2021 Breast Cancer Risk Gene Associations Refined in Large-Scale Studies Jan 11, 2021 Glioblastoma Transcriptomes Point to Mitochondrial Subtype, Potential Treatment Strategies Dec 22, 2020 Agendia FLEX Registry Powers Genomics Research on Underrepresented Breast Cancer Patients Premium Dec 21, 2020 Servier, Celsius Therapeutics Partner to Identify Colorectal Cancer Drug Targets Dec 18, 2020 UK Launches Public-Private iDx-Lung Consortium to Improve Early Detection of Lung Cancers Dec 10, 2020 Apis Assay Technologies, Moffitt Cancer Center to Evaluate RNA Biomarkers for Cancer Progression Load More Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week:Â Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
